Elevai Labs (ELAB) News Today $0.02 0.00 (-15.65%) (As of 11/15/2024 08:54 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period CORRECTION - Elevai Labs Inc.November 14, 2024 | globenewswire.comElevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business UpdateNovember 14, 2024 | globenewswire.comElevai Labs Inc. Announces Update and Extension of Pending Offer to ExchangeNovember 4, 2024 | markets.businessinsider.comElevai Labs Inc. Announces Update and Extension of Pending Offer to ExchangeNovember 4, 2024 | globenewswire.comElevai Biosciences highlights past preclinical data on EL-32October 22, 2024 | markets.businessinsider.comElevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of ObesityOctober 22, 2024 | globenewswire.comElevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of ObesityOctober 21, 2024 | globenewswire.comElevai Labs commences exosome skincare studyOctober 4, 2024 | uk.investing.comElevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred StockOctober 4, 2024 | globenewswire.comREPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist CombinationsOctober 3, 2024 | globenewswire.comElevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist CombinationsOctober 3, 2024 | globenewswire.comElevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy DeviceOctober 2, 2024 | globenewswire.comElevai Labs (NASDAQ:ELAB) Stock, Short Interest ReportOctober 1, 2024 | benzinga.comElevai Labs stock offering raises $8 millionSeptember 27, 2024 | bizjournals.comAltium Capital Management LP Acquires New Stake in Elevai Labs IncSeptember 27, 2024 | finance.yahoo.comUnivest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB)September 24, 2024 | globenewswire.comElevai Labs shares tumble on pricing of new stock offeringSeptember 24, 2024 | bizjournals.comDow Gains Over 50 Points; Elevai Labs Shares PlummetSeptember 23, 2024 | benzinga.comWhy Elevai Labs (ELAB) Stock Is Down 60% TodaySeptember 23, 2024 | msn.comElevai Labs Inc. Announces Pricing of $8.0 Million Public OfferingSeptember 23, 2024 | globenewswire.comElevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma ApplicationsSeptember 10, 2024 | globenewswire.comElevai Labs files for 25M stock offeringSeptember 6, 2024 | msn.comMicro Cap Stealing Premarket Show Before Tuesday's Opening BellSeptember 4, 2024 | msn.comElevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome TechnologySeptember 3, 2024 | globenewswire.comPE RatioAugust 28, 2024 | seekingalpha.comElevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™August 28, 2024 | globenewswire.comElevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome SerumAugust 26, 2024 | globenewswire.comElevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health ApplicationsAugust 19, 2024 | globenewswire.comElevai Labs Inc. (ELAB)August 15, 2024 | finance.yahoo.comElevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 14, 2024 | globenewswire.comElevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhDJuly 30, 2024 | globenewswire.comTop 4 Risk Off Stocks You'll Regret Missing In JulyJuly 16, 2024 | benzinga.comElevai Labs Forms New Scientific Advisory Board for its Weight Loss ProgramsJune 14, 2024 | globenewswire.comElevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in StockholmMay 29, 2024 | finance.yahoo.comElevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 ConferenceMay 22, 2024 | finance.yahoo.comElevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 ConferenceMay 22, 2024 | globenewswire.comELAB Stock Earnings: Elevai Labs Reported Results for Q1 2024May 16, 2024 | investorplace.comElevai Labs Inc. Reports First Quarter 2024 Financial ResultsMay 15, 2024 | finance.yahoo.comElevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of ObesityMay 2, 2024 | globenewswire.comElevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome SkincareMay 1, 2024 | globenewswire.comElevai Labs in deal to develop co-treatments for weight-loss drugsMay 1, 2024 | bizjournals.comElevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity TreatmentsMay 1, 2024 | globenewswire.comElevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue CommitmentsApril 29, 2024 | globenewswire.comELAB Elevai Labs, Inc.April 25, 2024 | seekingalpha.comELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 MonthsApril 22, 2024 | globenewswire.comElevai Labs, Inc. (ELAB)April 20, 2024 | finance.yahoo.comELAB Stock Earnings: Elevai Labs Reported Results for Q4 2023April 2, 2024 | investorplace.comElevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial ResultsMarch 29, 2024 | globenewswire.comELEVAI launches consumer skincare portalMarch 20, 2024 | investing.comElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical MarketMarch 18, 2024 | globenewswire.com Get Elevai Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too? Click Here For Your Free Guide ELAB Media Mentions By Week ELAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELAB News Sentiment▼0.180.56▲Average Medical News Sentiment ELAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELAB Articles This Week▼41▲ELAB Articles Average Week Get Elevai Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OGEN News DRMA News BON News CYTO News KRBP News TRVN News ADTX News REVB News TFFP News PXMD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELAB) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevai Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevai Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELAB Stock Alerts